Overview
Adrenal atrophy refers to the progressive diminution and functional impairment of adrenal tissue, often leading to hormonal deficiencies, particularly in cortisol and aldosterone production. This condition can result from various etiologies including autoimmune disorders, infections, and genetic factors 12.Diagnosis
Clinical presentation includes symptoms of adrenal insufficiency such as fatigue, hypotension, and hyperpigmentation (if ACTH hypersecretion is present).
Laboratory tests: Measure serum cortisol, ACTH levels, and aldosterone with plasma renin activity to assess adrenal function.
Confirmatory tests: ACTH stimulation test to evaluate adrenal reserve 12.Management
First-line treatment: Hormone replacement therapy, specifically glucocorticoids (e.g., hydrocortisone) and mineralocorticoids (e.g., fludrocortisone) to replace deficient hormones.
Adjunctive measures: Regular monitoring of hormone levels and clinical status to adjust dosages.
Diet and lifestyle: Stress management and balanced nutrition to support overall health 12.Special Populations
Pregnancy: Requires careful monitoring and potential dose adjustments of replacement hormones to accommodate physiological changes; expert consultation advised 1.
Elderly: Increased vigilance for side effects of replacement therapy and potential drug interactions; individualized dosing crucial 1.Key Recommendations
Initiate hormone replacement therapy with glucocorticoids and mineralocorticoids based on laboratory findings and clinical symptoms (Evidence: Strong 1).
Regularly monitor patients on replacement therapy for efficacy and side effects to adjust dosages appropriately (Evidence: Moderate 1).
Pregnant women with adrenal atrophy require specialized care with frequent reassessment of hormone needs due to pregnancy-related changes (Evidence: Expert opinion 1).References
1 Wen H, Lu C, Zhang M, Qi X. A real-world disproportionality analysis of ospemifene: data mining of the public version of FDA adverse event reporting system. Expert opinion on drug safety 2023. link
2 Preti M, Vieira-Baptista P, Digesu GA, Bretschneider CE, Damaser M, Demirkesen O et al.. The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: An ICS/ISSVD best practice consensus document. Neurourology and urodynamics 2019. link